Veradigm Payerpath Ranks First in End-To-End Revenue Cycle Management (RCM) Software Technology from Black Book™ Research
2022
Veradigm Payerpath is an end-to-end revenue cycle management suite of solutions built to assist medical practices of all sizes and specialties improve revenue, streamline communications with payers and patients, and boost practice profitability. The system’s integrated solutions are practice management (PM) agnostic, interfacing seamlessly with all major PM systems. An innovative claims management platform, Veradigm Payerpath delivers a >
Black Book collects ballot results on 18 performance areas of operational excellence to rank vendors by software, systems, products, equipment and outsourced service lines. Client users submit ballots per vendor per function which are juxtaposed with client size, functions outsourced, software installed, systems employed, services rendered, industry/vertical(s) affected, country of service origin and overall service and/or product line domain.
Click here to read Black Book’s methodology.
“Payerpath is one of our advanced solutions that connects payers, providers, patients, and government to streamline and simplify care,” said
About Veradigm®
Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. Some healthcare technology companies deliver clinical data for biopharma and health plans, some help turn that data into insights, others serve healthcare providers directly by providing point-of-care clinical software and patient outreach platforms. Veradigm does it all. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.
For more information on Veradigm, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube
About
© 2022
- Veradigm Payerpath 2021. Data on file.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220906005300/en/
Investors:
312-506-1237
Jenny.Gelinas@allscripts.com
Media:
312-447-2466
concetta.rasiarmos@allscripts.com
Source: